Loading stock data…
Envista Holdings Corporation (NVST)
$26.81-0.47 (-1.72%)
Market ClosedLast close Sep 8
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Envista Holdings Corporation in the Healthcare sector is trading at $26.81 with a market capitalization of $4.3B. Wall Street consensus targets $30.79 (14 analysts), implying a +14.8% move over the next 12 months. The stock is currently 12% below its 52-week high of $30.42, remaining 5.8% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +14.8% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $730.50M↑ | $705.50M↓ | $750.60M↑ | $669.90M↓ | $682.10M |
| Gross Profit | $407.00M↑ | $390.10M↓ | $410.60M↑ | $370.20M | $369.90M |
| Operating Income | $80.30M↑ | $66.20M↓ | $93.00M↑ | $57.50M↑ | $46.30M |
| Net Income | $53.70M↑ | $38.70M↑ | $32.90M↑ | -$30.30M↓ | $26.40M |
Peer Comparison
JNJUNHPFE
Fundamentals
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Eq...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.31B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
46.22
Beta
Defensive asset. Lower volatility than the S&P 500.
0.86
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.09%
Volume
Today's trading volume
2.48M
Recent News
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.
Envista (NVST) Up 0.8% Since Last Earnings Report: Can It Continue?
Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
1 Stock Under $50 Worth Your Attention and 2 Facing Challenges
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
Envista Holdings Shares Rise After JPMorgan Upgrade
Envista Holdings Corp. (NYSE:NVST) shares rose 2.
Broadcom upgraded, Ultragenyx downgraded: Wall Street's top analyst calls
Broadcom upgraded, Ultragenyx downgraded: Wall Street's top analyst calls